Cancer and Complementary Therapies: Current Trends in Survivors' Interest and Use.

Author: Qureshi M1, Zelinski E2, Carlson LE1,3,2
Affiliation:
11 University of Calgary, Calgary, AB, Canada.
23 Alberta Health Services-Cancer Care, Calgary, AB, Canada.
32 Tom Baker Cancer Centre, Calgary, AB, Canada.
Conference/Journal: Integr Cancer Ther.
Date published: 2018 Apr 1
Other: Volume ID: 1534735418762496 , Special Notes: doi: 10.1177/1534735418762496. [Epub ahead of print] , Word Count: 232


BACKGROUND: Cancer survivors use complementary therapies (CTs) for a variety of reasons; however, with interest and use reportedly on the rise and a widening range of products and practices available, there is a need to establish trends in and drivers of interest. We aimed to determine (1) frequencies of use, level of interest, and barriers for 30 specific CTs and (2) whether physical symptoms, perceived stress (PS), or spiritual well-being were related to interest levels.

METHOD: A total of 212 cancer outpatients were surveyed at the Tom Baker Cancer Centre in Calgary, Canada.

RESULTS: Overall, up to 75% of survivors already used some form of CTs since their diagnosis. The most highly used were the following: vitamins B12 and D, multivitamins, calcium, and breathing and relaxation exercises. Those who had not used CTs indicated highest interest in massage, vitamin B12, breathing and relaxation, mindfulness-based stress reduction, and antioxidants. The most frequently reported barriers for all CTs were not knowing enough about what a therapy was and not having enough evidence on whether it worked. High PS predicted higher interest for all CTs, but spirituality was not significantly related to any. Physical symptoms, anxiety, and depression were significant predictors of interest for some CTs.

CONCLUSION: These findings provide a blueprint for future clinical efficacy trials and highlight the need for clinical practice guidelines.

KEYWORDS: barriers; cancer; clinical practice guidelines; complementary medicine; complementary therapies; interest; predictors; use

PMID: 29629606 DOI: 10.1177/1534735418762496

BACK